Simplex Trading
CLGN icon

Simplex Trading’s CollPlant Biotechnologies CLGN Stock Holding History

Simplex Trading’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200
Closed -$3K – 10487
2021
Q4 		$3K Buy
+200
New +$3.57K ﹤0.01% 9801

Other funds holding CLGN

SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $1.95B AUM 15.9% 1-Year Est. Return

Simplex Trading's CLGN Position: Q1 2026 in Review

Simplex Trading opened a new position in CollPlant Biotechnologies (CLGN) in Q1 2026: 118 shares worth $63. The stake represents ﹤0.01% of the portfolio and ranks #8892 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CLGN as recently as Q3 2025.

Simplex Trading first reported a position in CLGN in Q4 2021 and has held it in 7 quarters since. The position peaked at $26K in Q4 2021. 21 funds tracked by Wall St. Rank hold CLGN as of Q1 2026.

  • Simplex Trading held 118 shares of CollPlant Biotechnologies worth $63 as of Q1 2026.
  • CollPlant Biotechnologies was a new Simplex Trading position in Q1 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8892 holding.
  • Simplex Trading first reported a position in CollPlant Biotechnologies in Q4 2021 and has held it in 7 quarters since.
  • Simplex Trading's CollPlant Biotechnologies position peaked at $26K in Q4 2021.
  • 21 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.